about
The germinal center antibody response in health and diseaseSelf-assembling protein nanoparticles in the design of vaccinesStructural and Computational Biology in the Design of Immunogenic Vaccine AntigensEmerging Vaccine TechnologiesPaths to a malaria vaccine illuminated by parasite genomicsA high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopesCryo-electron microscopy structure of a coronavirus spike glycoprotein trimerStructure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial VirusDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityA Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected CellsApplying contemporary immunology to elucidate heterologous effects of infant vaccines and to better inform maternal-infant immunization practices.Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GReverse vaccinology 2.0: Human immunology instructs vaccine antigen designAnalysis of Human RSV Immunity at the Molecular Level: Learning from the Past and PresentProtein Crystallography in Vaccine Research and DevelopmentA Rationally Designed TNF-α Epitope-Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen-Induced Arthritis in MiceMost neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunitsDe novo design of a four-fold symmetric TIM-barrel protein with atomic-level accuracyStructure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopyEpitope specific T-cell responses against influenza A in a healthy population.Rapid search for tertiary fragments reveals protein sequence-structure relationshipsComputational tools for epitope vaccine design and evaluationVaccines, new opportunities for a new society.Achievements and Challenges in Computational Protein Design.Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth.Rapid fine conformational epitope mapping using comprehensive mutagenesis and deep sequencing.Classification of self-assembling protein nanoparticle architectures for applications in vaccine designChimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.Probing the Impact of Local Structural Dynamics of Conformational Epitopes on Antibody Recognition.Transplanting supersites of HIV-1 vulnerability.In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers.RNA virus reverse genetics and vaccine design.Options and obstacles for designing a universal influenza vaccinePassive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibodyIdentification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannosePalivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platformA site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL.
P2860
Q26745929-19D1D080-0DB0-4903-8FEC-1CEEA69FEB77Q26767097-9D382830-17FF-41F3-BBB8-EB0F82C081C3Q26777382-2A7DE9EC-CAE3-4D03-BA96-A52A7D424757Q26783764-D6D12B93-A9AB-4FB8-BBA4-23BF9A61A1F1Q26853267-0E2DF543-2110-453D-9991-3787E14860D7Q26860116-A6EBA048-CCEC-41F6-B9D9-E3D19221C90AQ27314711-02B30F6F-28F8-477D-85B6-92630F385C48Q27333522-339FB415-B356-4055-99BA-9AB9E11F1EF9Q27654848-47D6F025-5D72-47ED-BE4D-A7171E029A2BQ27684407-D539A53B-8A34-4163-9172-7A7086D8FCC4Q27687122-CE69DB72-7E49-4240-8F42-21CE5DD5DC75Q27704710-FDA40D57-F121-4E3F-9708-2E6D9BB54C0BQ28075274-0285C68E-5607-405A-B867-15DD7170CD7EQ28080556-7BD691A8-4923-49A1-8ABF-650DC0BD6A6AQ28087528-0BE4C431-0B6E-47A2-B4B3-21A7EC129EA5Q28554288-53A9F421-FDF5-4648-8CA9-B79C36F5E26AQ28602816-0EC5E17E-464D-4F20-AA8C-A678F35375CFQ28603894-E5370D16-5879-4BC1-8F83-ECC0FEDD72F3Q28654490-B50A6205-CE44-4C4C-BE34-5DE8035DE26FQ30202358-3D89039E-390C-4FB4-8352-7AA87CBFE1C3Q30368904-817C9B03-DF50-4BA3-9568-8DFA7B9E2864Q30373339-F5F9056B-01FE-4D52-8436-78B8B2D0D15EQ30390904-9F380B3E-9D4C-410B-B0B3-E4430D54756AQ30395939-01481C1D-4766-4BF2-AF0D-3DAB82064060Q30657338-A8EAFBD6-5903-4B42-B778-24B53C1B40F2Q30677297-43496963-08E3-43D5-BF84-55926D93C09BQ33630220-0CBD1B16-BBEA-43FF-A2EC-A8D02287E526Q33743992-F8AFF037-08FC-435E-94B1-DF484CC2803BQ33821896-C32F5440-6ECE-4665-9A3B-07F7DD65578FQ33854841-061D4933-8445-4673-B233-71FEC0E0ADF7Q33867337-2B5FE5FF-2DAA-4BB5-B55E-F52BA2AF5CABQ33963398-BF97280B-D8E7-400D-A5AD-5EFFF41475B5Q34102290-6A0173C8-FD87-4A50-8435-5589F6C4332BQ34230556-F6F2F5E2-D992-4934-9519-F087D6EB7BD6Q34661129-AB4153BF-5EEB-4AC6-B13C-53D0C239E10AQ35031839-DE1E6CA8-4D0E-4935-8BFE-3DECE947A24EQ35119778-FDF8B4FD-D2D5-4D18-9D6F-7555C8547D38Q35535626-4EF11CAF-CFCB-497E-ABB4-85614BD8DC3AQ35591551-970D5F7B-4EBC-4047-A750-91F38EF6BCDCQ35616152-2D052147-B7B3-473A-8943-B93D81D3CB46
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Proof of principle for epitope-focused vaccine design
@ast
Proof of principle for epitope-focused vaccine design
@en
Proof of principle for epitope-focused vaccine design
@nl
type
label
Proof of principle for epitope-focused vaccine design
@ast
Proof of principle for epitope-focused vaccine design
@en
Proof of principle for epitope-focused vaccine design
@nl
prefLabel
Proof of principle for epitope-focused vaccine design
@ast
Proof of principle for epitope-focused vaccine design
@en
Proof of principle for epitope-focused vaccine design
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Proof of principle for epitope-focused vaccine design
@en
P2093
Alexandria Schroeter
Andreia M Serra
Bruno E Correia
Colin Correnti
Eric Stevens
Gretchen Baneyx
Joseph G Jardine
Margaret A Holmes
Mary J Connell
P2860
P2888
P3181
P356
10.1038/NATURE12966
P407
P577
2014-03-13T00:00:00Z
P5875
P6179
1031434303